ALKBH5 and neoplasm: The inhibitory effect of anti-PD-L1 therapy on tumor growth was attenuated in ALKBH5-knockdown mice, suggesting that lung cancer cells with high ALKBH5 expression are more sensitive to anti-PD-L1 therapy (Fig. 8K).